Camber Pharmaceuticals, a generic drugs supplier, presented Target with its "Outstanding Partnership" award for 2014.
According to a report released Monday by Thomson Reuters BioWorld, currently there are 700 follow-on biologics therapies moving through pipelines with many already approved.
Diplomat Pharmacy on Monday announced that it has commenced its initial public offering of 13.3 million shares of its common stock.
CARE Pharmacies last week announced that they have selected PDX’s Enterprise Pharmacy System as the regional drug chain’s pharmacy system of choice.
Cardinal Health Specialty Solutions and KEW Group agree to make KEW's diagnostic services available to Specialty Solutions' community oncology customers.
Drug Store News director of continuing education and clinical content Suzanne Feeney, PharmD, will take over the Drug Store News twitter handle @drugstorenews, as part of the global #Pharmacist tweet-a-thon on Thursday, Oct. 2.
Boehringer Ingelheim Pharmaceuticals announced that the Food and Drug Administration approved Spiriva Respimat (tiotropium bromide) inhalation spray as a treatment for bronchospasm associated with chronic obstructive pulmonary disease.
Actavis on Friday confirmed that it has filed an abbreviated new drug application with the Food and Drug Administration to market buprenorphine transdermal system, a generic version of Butrans from Purdue Pharma.
Camber Pharmaceuticals announced the launch of raloxifene hydrochloride, USP tablets in 60-mg dosage strengths.
Celgene Corp. earlier this week announced that the Food and Drug Administration approved Otezla (apremilast) for the treatment of moderate to severe plaque psoriasis. The drug is the first and only PDE4 inhibitor approved for the treatment of plaque psoriasis, according to the company.